Background/Aims: The proliferation of human bronchial smooth muscle cells (HBSMCs) is a key pathophysiological component of airway remodeling in chronic obstructive pulmonary disease (COPD) for which pharmacotherapy is limited, and only slight improvements in survival have been achieved in recent decades. Cigarette smoke is a well-recognized risk factor for COPD; however, the pathogenesis of cigarette smoke-induced COPD remains incompletely understood. This study aimed to investigate the mechanisms by which nicotine affects HBSMC proliferation. Methods: Cell viability was assessed with a CCK-8 assay. Proliferation was measured by cell counting and EdU immunostaining. Fluorescence calcium imaging was performed to measure intracellular Ca 2+ concentration ([Ca 2+ ] i ). Results: The results showed that nicotine promotes HBSMC proliferation, which is accompanied by elevated storeoperated calcium entry (SOCE), receptor-operated calcium entry (ROCE) and basal [Ca 2+ ] i in LY294002 inhibited the protein expression levels of TRPC6. Conclusion: Herein, these data pathway plays an important role in the physiological regulation of airway smooth muscle cell proliferation, representing an important target for augmenting airway remodeling.
Nicotine-Induced Airway Smooth Muscle Cell Proliferation Involves TRPC6-ependent Calcium In u ia nAChR

Introduction
Airway remodeling has been described in a number of chronic airway diseases, including chronic obstructive pulmonary disease (COPD) and asthma, and it is characterized by the hypertrophy and/or hyperplasia of smooth muscle cells [1] . Recent studies have demonstrated a clear association between cigarette smoke and COPD [2] [3] [4] . Cigarette smoke has been reported to induce features of airway remodeling in COPD animal models, including airway wall thickening, increased airway smooth muscle (ASM) mass, goblet cell hyperplasia and collagen deposition [5] . The effects of nicotine, the major active and addictive component of tobacco [6] , have been described in certain cell types, including bronchial smooth muscle cells [7] . We previously demonstrated that nicotine regulates cellular proliferation in rat airway smooth muscle cells (RASMCs) by activating the Akt signaling pathway [8] . However, the precise mechanism by which nicotine induces damage to airways remains largely unknown.
Previously, Feng's group developed a nicotine-dependent C. elegans model and determined that nicotinic acetylcholine receptors (nAChRs) were required for the behavioral responses to nicotine, suggesting the functional conservation of nAChRs in response to nicotine. The authors also observed that mutant worms lacking canonical transient receptor potential proteins (TRPCs) showed defective responses to nicotine that could be rescued by human TRPCs. These indings revealed an important role of TRPCs in regulating nicotinedependent behavior [9] . However, literature regarding the link between TRPCs and nAChRs is limited.
TRPCs are encoded by genes that are most closely related to the trp gene, which was originally identi ied in Drosophila. Currently, the TRPC family is known to consist of seven members, designated TRPC1-7 [10] , which are highly permeable to calcium. TRPCs have recently emerged as important players in controlling the function of smooth muscle cells [11, 12] . Recent studies have shown that TRPC genes, which encode store-operated Ca 2+ channels (SOCC) and receptor-operated Ca 2+ channels (ROCC), play important roles in the regulation of intracellular calcium homeostasis and cell proliferation [13] [14] [15] . Evidence suggests that SOCC mediates store-operated Ca 2+ entry (SOCE) and ROCC mediates receptoroperated Ca 2+ entry (ROCE). However, the in luence of nicotine on TRPCs in H SMCs has not been determined.
We previously showed that nicotine elevates intracellular Ca 2+ concentration ( [Ca 2+ ] i ) in ASMCs through 7 nAChR-mediated signals pathways and highlighted the possibility that 7 nAChR could be considered a potential target for the treatment of airway remodeling [16] . However, information concerning the precise mechanism is lacking. nAChRs are non-speci ic cation channels that are widely expressed in the nervous system (neuronal nAChRs) and in skeletal muscle (muscle nAChRs). Among nAChRs, 7 nAChR are formed by the homomeric assembly of ive subunits and are generally considered to be preferentially permeable to calcium [17, 18] . However, the expression and function of 7 nAChR in H SMCs remain unclear. Given available information, targeting 7 nAChR has been considered a viable strategy for the treatment of a variety of diseases that involve the use of nicotine [19] [20] [21] .
Dysfunction of the PI3K/Akt signaling pathway has been implicated in many human diseases, including COPD [22, 23] . In addition, various calcium-dependent signaling cascades are directly or indirectly in luenced by the PI3K/Akt signaling pathway [22] via kinases and phosphatases. We previously showed that nicotine can induce activation of the Akt signaling pathway in RASMCs [8] .
Therefore, the present study was designed to explore the function of nicotine in human bronchial smooth muscle cells (H SMCs). We hypothesized that nicotine has a stimulatory effect on H SMCs, promoting cell proliferation through an 7 nAChR-mediated mechanism that is dependent on intracellular calcium homeostasis and involves the PI3K/Akt signaling pathway. 
Materials and Methods
Materials
Five H SMC lines were obtained from ScienCell ( SA, Cat. o. 3400), an Ed cell proliferation assay kit was obtained from Ribo io (Guangzhou, China), and 10 Cell ysis uffer was obtained from Cell Signaling Technology ( everly, MA, SA). Anti-TRPC1, 3, 4, 6 were obtained from Alomone abs ( erusalem, Israel). Anti-7 nAChR were obtained from Santa Cruz (Cambridge, MA, SA). Fura 2-AM was obtained from Invitrogen (Carlsbad, CA, SA). An 7 nAChR-selective antagonist (methyllycaconitine, M A), an 7 nAChRspeci ic antagonist (MG624) and a phosphoinositide 3-kinase (PI3K) inhibitor ( 294002) were obtained from Sigma (St. ouis, MO, SA).
Cell culture
Primary H SMCs and smooth muscle cell medium (SMGM) were purchased from ScienCell ( SA). H SMCs were cultured in SMGM containing 2 fetal bovine serum (F S) and 1 smooth muscle cell growth supplement. The medium was replaced every two days. Cells were incubated in a humidi ied atmosphere containing 5 CO 2 and 95 O 2 at 37°C. Cells at passages 3 and 8 were used for experiments.
Cell viability assay
To evaluate the cytotoxicity of nicotine on H SMCs, a Cell Counting kit-8 (CCK-8) assay (Dojindo aboratories, Kumamoto, apan) was performed. In brief, H SMCs were seeded at a density of 2 10 3 cells/ well in 96-well plates and were allowed to attach overnight. Cells were treated with nicotine at different concentrations (0.01 M, 0.1 M, 1 M, 10 M, 100 M and 1000 M) and continuously cultured for 0, 24, 48 and 72 h. Six repeats were prepared for each group. CCK-8 solution (10 μl) was added to each well for 3 h, and then the absorbance at 450 nm was measured using a microplate spectrophotometer (Thermo Scienti ic, Rockford, I , SA). The cytotoxic effect was indicated as a percentage of surviving cells (ratio of surviving cells after treatment to surviving cells without treatment) using the following formula: Cell viability = [A450 (treated group) -A450 (blank group)/[A450 (negative group) -A450 (blank group)] 100 .
Cell proliferation assays
Cell proliferation was analyzed by cell counting and Ed immunostaining. For cell counting, 35000 H SMCs were plated in 6-well plates with 1 ml SMGM. After 24 h, the cells were washed and transferred to 0.2 F S-containing DMEM-F12 for 24 h. After an additional 24 h, the cells were treated with 10 M nicotine for 48 h. In each experiment, at least three wells were used for each condition. At the end of each experimental period, the cells were harvested with trypsin-EDTA and counted using a Zeiss Coulter Counter ( eckman Coulter, Miami, F , SA). A Cell-ight Ed staining kit was used for the vitro labeling of the nuclei of dividing cells. H SMCs were seeded in triplicate into 96-well plates at a density of 1 10 4 cells per well and incubated in SMGM overnight. Then, the cells were treated with 10 -5 M nicotine. All Ed -incorporation experiments were performed according to the manufacturer's protocol [24, 25] . One hundred microliters of 50 M Ed were added to each well for 2 h. The cells were ixed by using 4 paraformaldehyde and incubated with 2 mg/ml aminoacetic acid for 5 min with oscillation. The cells were incubated with 100 of penetrant per well for 10 min under oscillation followed by 100 of 1 Ed solution for 30 min. Hoechst 33342 was used to stain the cell nuclei. Images were acquired under a luorescence microscope. For each Ed experiment, three random ields were imaged at 20 objective magni ication, and the fraction of Edpositive cells was expressed as the percentage of the total number of cells in each ield.
RT-PCR and real-time PCR
Total R A in H SMCs was extracted using TRIzol (Invitrogen, arcelona, Spain) following the manufacturer's instructions. Reverse transcription and PCR were performed using a Super Script cD A synthesis kit (Takara iotechnology, China) and KOD F (To o o, apan), respectively. Real-time quantitative PCR was conducted by using Sso Fast Eva Green SuperMix ( io-Rad, Hercules, CA, SA) with a Stratagene M 3000P real-time PCR detection system. Detection threshold cycle (CT) values were obtained using M 3000P software. The relative concentrations of each transcript were calculated by using the Ct method. The mR A copies were normalized and expressed as the percent change from control values. The primer sequences were synthesized by TAKARA iotechnology, and the details of the sequences are listed in Table 1 .
Western blot analysis
H SMCs were harvested in 10 Cell ysis uffer with PMSF, and the total protein concentration was determined by CA protein assay (Pierce, Rockford, I ). The proteins g) were separated by gel electrophoresis and transferred onto polyvinylidenedi luoride (P DF) membranes (pore size 0.45 M, io-Rad). The membranes were blocked with 5 milk in T Sblocking buffer and incubated overnight at 4°C with primary antibodies. The blots were washed and incubated with HRP-conjugated secondary antibody at RT for 1 h. Signals were then detected using an enhanced EC chemiluminescence system ( io-Rad, Hercules, CA, SA) and quanti ied by densitometry with image analysis software (Image ).
Measurement of intracellular Ca
2+
The [Ca 2+ ] i was measured in H SMCs by using fura-2 dye, which is a Ca
-sensitive luorescent dye. The cells were incubated with 5 μM fura-2 (Molecular Probes) for 40 min at 37°C, washed three times, and then maintained at room temperature for an additional 30 min to allow for complete de-esteri ication of the intracellular AM esters. Coverslips with H SMCs were then mounted onto a closed polycarbonate chamber clamped in a heated aluminum platform (PH-2; Warner Instrument, Hamden, CT, SA) on the stage of a eica inverted microscope (Melville, , SA). The chamber was perfused at 0.5 ml/min with Krebs-Ringer bicarbonate solution (KR S) containing (in mM) 118 aCl, 4.7 KCl, 0.57 MgSO 4 , 2.5 CaCl 2 , 1.18 KH 2 PO 4 , 25 aHCO 3 and 10 glucose. The KR S was equilibrated with 16 O 2 -5 CO 2 at 37°C in heated reservoirs and added to the chamber through stainless steel tubing. The chamber temperature was maintained at 37°C with an in-line heat exchanger and a dual channel heater controller (SF-28 and TC-344 , Warner Instruments). Fluorescent emissions were acquired at 510 nm from regions of interest corresponding to a single cell after excitation at 340 and 380 nm (shift in excitation wavelength upon binding to Ca
) in 15~30 cells using a xenon arc lamp. The 340/380 nm emission luorescence ratio, which is known to be proportional to [Ca 2+ ] i , is shown for most of the data.
We irst measured [Ca 2+ ] i at 12-s intervals before and after the restoration of extracellular [Ca 2+ ] i to 2.5 mM. SOCE was evaluated based on the increase in [Ca 2+ ] i caused by the restoration of extracellular [Ca 2+ ] i in the continuous presence of nifedipine and cyclopiazonic acid (CPA). ROCE was evaluated based on the increase in [Ca 2+ ] i caused by the restoration of extracellular [Ca 2+ ] i in the continuous presence of nifedipine and 1-oleolyl-2-acetyl-sn-glycerol (OAG).
SOCE and ROCE were further quanti ied by quenching fura-2 luorescence with MnCl 2 (200 mol/ ). Fura-2 was excited at 360 nm in 30-s intervals. After a stable baseline of luorescence was attained, Mn 2+ was applied to determine the maximum rate of the quenching of fura-2 luorescence.
siRNA knockdown H SMCs were seeded and grown to 60 con luence in six-well plates. A speci ic siR A against TRPC6 (siTRPC6) and non-targeted siR A (si T) were synthesized ( ife Technologies, Gaithersburg, MD, SA) and used to transfect H SMCs with serum-free Opti-MEM at a inal concentration of 50 nM, according to the manufacturer's instructions. siR A transfection was monitored under a luorescence microscope after 24 h, and the ef iciency of the siR A-mediated gene silencing was evaluated by western blot analysis. The medium was removed to measure TRPC6 protein expression at 48 h after transfection. All the cell groups in the experiments consisted of three replicates.
Statistical analyses
The data were analyzed using SPSS16.0 statistical software. The data are presented as the mean ± SD. The results are representative of at least n = 3 unless otherwise indicated. Differences between groups were 
Results
We irst assayed the cytotoxicity of nicotine on H SMCs by CCK-8 assays. The viability of the H SMCs did not change when the cells were treated with nicotine below 0.1 M at different time points. However, the cell viability of H SMCs was signi icantly increased by nicotine at the concentration of 1-10 M. Moreover, the cell viability of H SMCs treated with 10 M nicotine reached a peak at 48 h. However, a time-and dose-dependent decrease in cell viability was observed at higher doses of nicotine (more than 10 M) (Fig. 1A) . This result implied that a wide concentration range of nicotine (1-10 M) can promote proliferation in H SMCs. According to this result, the nicotine concentration of 10 M and the drug treatment time of 48 h were adopted in the following in-vitro experiments. ext, we demonstrated that the cell viability increase resulted from the increase in cell numbers (Fig. 1 ) due to exposure to 10 M nicotine. To verify the upregulation of cell proliferation related to cell cycle progression, we evaluated the S-phase cell ratio of H SMCs by luorescent Ed . We found that the S-phase cell ratio of the H SMCs was remarkedly increased by 48 h treatment of 10 M nicotine (Fig. 1C) . These results indicated that 10 M nicotine provokes proliferation of H SMCs. It is well accepted that nicotine exerts its effects by activating nAChRs [8, 16] . To determine whether nAChRs play a role in the nicotine-induced proliferation of H SMCs, we treated H SMCs with the non-speci ic pharmacological nAChR antagonist M A or the 7 nAChR-speci ic antagonist MG624 and then measured cell proliferation. Data showed that pretreatment with 100 M M A or 1 M MG624 attenuated nicotine-induced increase of H SMCs proliferation (Fig. 1D) . Direct cell counting revealed that M A or MG624 inhibited nicotine-induced upregulation of the number of H SMCs (Fig. 1E) . These results implied that 7 nAChR plays a pivotal role in nicotine-mediated cell proliferation of H SMCs. To further support this inding, 7 nAChR-speci ic siR A was used in the following experiments. As shown in Fig. 1F -G, nicotine-mediated enhancement of H SMC proliferation could be suppressed by 7 nAChR-speci ic siR A. Thus, we concluded that the pro-proliferation effect of nicotine on H SMCs was nAChR-dependent and that among nAChRs, 7 nAChR may play a major role.
Nicotine exposure enhanced SOCE and ROCE in HBSMCs
An important mechanism of smooth muscle cell proliferation is the maintenance of intracellular calcium homeostasis. Increased [Ca 2+ ] i has been proven to promote smooth muscle cell proliferation. As a type of calcium channel, TRPCs can facilitate calcium in lux, which may further evoke SOCE and ROCE, inally leading to elevation of cytoplasmic calcium levels. SOCE can be activated by depletion of Ca 2+ stores using CPA or thapsigargin, whereas ROCE can be activated directly by diacylglycerol (DAG) via a protein kinase C-independent mechanism. As a membrane-permeable analogue of DAG, OAG is commonly used as a ROCE activator. To determine whether nicotine-induced H SMCs proliferation is associated with SOCE and/or ROCE, [Ca 2+ ] i were monitored by fura-2 luorescence imaging (340/380 nm ratio, F340/F380). As shown in Fig. 2A , SOCE activated by depletion of Ca 2+ stores with CPA signi icantly increased in H SMCs treated by 10 M nicotine for 48 h (0.66 ± 0.10 for nicotine treatment cells, and 0.38 ± 0.04 for control cells; P 0.05). Consistent with SOCE, ROCE activated directly by OAG was also signi icantly elevated in H SMCs treated by 10 M nicotine for 48 h (0.38 ± 0.01 for nicotine treatment cells, and 0.18 ± 0.01 for control cells; P 0.05; Fig. 2 ).
With the 48 h treatment of 10 M nicotine, the increases in both SOCE and ROCE resulted in a signi icant rise in basal [Ca 2+ ] i in H SMCs (1.01 ± 0.05 for nicotine treatment cells, and 0.83 ± 0.04 for control cells; P 0.05; Fig. 2C ). These results suggested that the expression of putative SOCC and ROCC and their functional activities were augmented in H SMCs proportional to nicotine treatment. SOCE and ROCE were further evaluated by the rate of Mn 2+ -quenched fura-2 luorescence. As shown in Fig. 2D , the rate of CPA-induced Mn 2+ quenching was increased from 33.45±2.17 in control H SMCs to 52.79±2.33 in nicotinetreated H SMCs, whereas the rate of OAG-induced Mn 2+ quenching was accelerated from 26.09±1.54 in control cells to 44.19±4 .96 in nicotine-treated cells (Fig. 2E) . Together, these results clearly indicated that both SOCE and ROCE are involved in nicotine-mediated enhancement of proliferation of H SMCs.
Nicotine exposure increased TRPC6 expression in HBSMCs
It is well accepted that TRPCs encode SOCC and ROCC based on their participation in calcium entry routes that were initially shown to be activated downstream of P C-coupled receptors [26] [27] [28] . Researchers have demonstrated that upregulation of these proteins is associated with contraction and proliferation of smooth muscle cells [10, 29] . In this study, we evaluated the mR A expression of the family of TRPCs to determine their changes in response to nicotine exposure in H SMCs. We con irmed that TRPC1, TRPC3, TRPC4 and TRPC6 mR A were expressed in H SMCs, while TRPC2, TRPC5 and TRPC7 mR A was not detected in H SMCs (Fig. 3A) . In addition, nicotine selectively increased the mR A and protein expression of TRPC6 in H SMCs (P 0.05), whereas the expression of TRPC1, TRPC3 and TRPC4 was unaltered after nicotine treatment (Fig. 3 -C) .
To validate whether nicotine-induced increase in TRPC6 expression is responsible for the enhanced calcium entry into H SMCs, H SMCs were transfected with speci ic siR A for TRPC6, and the changes in SOCE and ROCE were detected. Transfection with TRPC6 siR A signi icantly attenuated the increases of basal [Ca 2+ ] i (Fig. 3D), SOCE (Fig. 3E) and ROCE ( -quenching (Fig. 3G-H) . Furthermore, a signi icant attenuation of the ratio of Ed -positive H SMCs was detected after transfection with TRPC6 siR A in both the presence and absence of nicotine (Fig. 3I) . Similar changes in cell numbers were observed according to the cell counting results (Fig.  3 ) . Taken together, these results strongly suggested that the nicotine-induced upregulation of calcium entry was dependent on TRPC6 in H SMCs. TRPC6 is therefore a major determinant of both SOCE and ROCE in H SMCs. icotine exposure elevated [Ca 2+ ] i levels in H SMCs, which is believed to promote cell proliferation.
Nicotine activated the PI3K/Akt pathway in HBSMCs
The PI3K/Akt signaling pathway has been reported to be an important regulator of nicotine-mediated RASMC proliferation [8] . Therefore, we supposed that increased TRPC6 expression may be a downstream effect of the PI3K/Akt pathway in H SMCs. We irst checked if a component of this pathway, Akt, was activated after nicotine treatment. We found that nicotine increased the phosphorylation of Akt at Ser473 in a time-dependent manner (Fig.  4A) . The phosphorylation of Akt at Ser473 in H SMCs was remarkably increased after 15 to 30 min of 10 M nicotine exposure, whereas the total levels of Akt remained unchanged. However, pretreatment with a pharmacological inhibitor of PI3K ( 294002) effectively prevented the nicotine-induced phosphorylation of Akt (Fig. 4 ) . Our results demonstrated that nicotine-mediated activation of Akt depends on PI3K activity. We next studied the potential role of the PI3K/Akt pathway in the nicotine-induced elevation of calcium entry into H SMCs, which is also TRPC6 dependent. As shown in Fig.  4C -F, pretreatment with 294002 signi icantly inhibited the nicotine-induced increases in TRPC6 protein expression, basal [Ca 2+ ] i , SOCE and ROCE in H SMCs. Similar results were also obtained for the maximum rate of CPA/OAG-induced Mn 2+ -quenching (Fig. 4G-H) . Consistent with SOCE and ROCE, the nicotine-mediated promotion of the Ed -positive H SMC ratio (Fig. 4I ) and cell numbers that were observed based on cell counting (Fig. 4 ) could be signi icantly attenuated by 294002. These results provide further evidence that nicotineupregulated calcium entry in H SMCs involves activation of the PI3K/Akt signaling pathway.
To determine whether 7 nAChR might participate in the nicotine-induced activation of the PI3K/Akt signaling pathway, we evaluated the activation of Akt after treatment with nicotine combined with inhibition of 7 nAChR via its antagonists (M A or MG624) or speci ic siR A. The results revealed that pretreatment with 7 nAChR antagonists or siR A targeting 7 nAChR effectively prevented nicotine-induced phosphorylation of Akt (Fig. 5A-C) . These results imply that nicotine-induced activation of the PI3K/Akt signaling pathway mediates 7 nAChR. We deduced that PI3K/Akt pathway activation is the link between 7 nAChR and TRPC6. 
Discussion
COPD is characterized by irreversible remodeling of the airway walls, including thickening of the airway smooth muscle layer. The mechanisms underlying such remodeling of smooth muscle remain largely unknown, and the role of nicotine in this process has not been fully explored. The present study provides evidence strongly indicating that nicotine promotes cell proliferation by increasing basal calcium levels and calcium in lux in H SMCs, which result from the 7 nAChR-dependent activation of the PI3K/Akt pathway and upregulation of TRPC6 protein expression. These indings have important implications for our understanding of nicotine-induced cell proliferation and offer a mechanism by which TRPC6-dependent calcium entry occurs.
The proliferation of airway smooth muscle cells is a typical pathological change in COPD patients, which is primarily related to cigarette smoke [8, 30] . Traditionally, nicotine has been studied as the addictive component in cigarettes, but increasing evidence has indicated that nicotine is also a key factor in the initiation and progression of COPD. icotine hinders the hydration of mucus, promotes cell proliferation by causing calcium in lux in ASMCs, induces pro-in lammatory dendritic cell responses, and blocks neutrophil apoptosis [31] . Despite the absence of a clear understanding of nicotine-induced health risk, some manufacturers have suggested that using nicotine can help someone who extensively smoke quit their smoking habit, which is widely known to be hazardous to health. In this study, we demonstrated that the proliferation of H SMCs was markedly enhanced after exposure to the concentrations used in this study. The viability of H SMCs was also signi icantly increased after 48-h treatment of nicotine (10 M), which is similar to the concentration of nicotine in the lungs of smokers [32, 33] . The proliferation of ASMCs has been the focus of consideration and extensive research, as it is an important airway wall remodeling response in cigarette smokers with COPD [34] . Although many groups have identi ied mediators that have the potential to increase the proliferation of H SMCs, no groups have clearly reported the effects of nicotine on the proliferation of H SMCs. In the present study, the Ed incorporation and direct cell counting experiments clearly showed that nicotine promoted H SMC proliferation. This is consistent with previous indings that the upregulation of cell proliferation is associated with nicotine in some nonneuronal cells [8, [35] [36] [37] . Environmental factors such as cigarette smoke also contribute to airway diseases such as COPD, in which altered cell proliferation in airway smooth muscle is the key feature of airway remodeling. Thus, understanding the precise mechanisms by which nicotine affects airway structural and functional changes is vital. To better understand how nicotine enhances H SMC proliferation, we focused our research on the alterations of intracellular calcium homeostasis. Changes in [Ca 2+ ] i regulate a wide variety of cell functions, including gene expression, cell proliferation and cell death [38] [39] [40] . Several studies have recently suggested that calcium homeostasis is dysregulated in ASMCs from COPD patients. Calcium regulation is central to ASMCs and as an early signal in cell proliferation. Many mechanisms are involved in calcium regulation in ASMCs, among which calcium channels play a major role. The role of calcium entry channel proteins belonging to TRPC family has been recently identi ied in some cells such as vascular smooth muscle cells, mast cells, pancreatic -cells, podocytes and -lymphocytes [41] [42] [43] [44] [45] . Z Feng et al [9] . showed that the multiple effects of nicotine in C. elegans is dependent on nAChRs and downstream target TRPC protein, a major ion channel component for calcium in lux. Within the TRPC family, TRPC1/4/5 can be activated by calcium mobilization from intracellular stores mediated by inositol 1, 4,5-trisphosphate (IP3) or thapsigargin; this process is referred as SOCE. In addition, TRPC3/6/7 can be directly activated by DAG through a process known as ROCE [46, 47] . Our results showed that nicotine enhanced both SOCE and ROCE and inally led to an elevation of basal [Ca 2+ ] i in H SMCs. SOCE and ROCE are enhanced during PASMC proliferation to increase calcium in lux, which provides suf icient calcium for activation of the intracellular mechanisms responsible for cell proliferation and growth [48] .
We thus expected that more than one TRPC family member should be increased in H SMCs, at least one for SOCE and another for ROCE. However, our data showed that only TRPC6 was selectively increased in response to nicotine, while the other subtypes TRPC1/3/4 did not change in H SMCs. Interestingly, this inding differs from a previous study reporting that TRPC6 alone induced OAG-activated calcium in lux in human epithelial breast cancer cells [49] . It also differs from our previous study reporting that the enhanced ROCE due to upregulated TRPC6 is a novel pathogenic mechanism contributing to the increased basal [Ca 2+ ] i in pulmonary venous smooth muscle cells (P SMC) and excessive P SMC proliferation during the development of hypoxic pulmonary hypertension [50] . However, more recent studies have indicated that TRPC6 is also an important component of SOCC and contributes to the SOCE process [12, 51, 52] . Evidences have also shown that upregulation of TRPC6 expression increases SOCC activity, which is related to elevated SOCE, and inally promotes the proliferation of PASMCs [53, 54] . However, the reasons behind these discrepancies remain unclear. TRPCs have been shown to assemble as both homomeric and heteromeric complexes. Thus, it is dif icult to unambiguously assign speci ic functions to speci ic TRPCs, and in many cases, the functions of various TRPCs may overlap. In PASMCs, the detection of the putative receptor-operated channel TRPC6, in addition to TRPC1, suggested the presence of ROCE pathway [55] . However, it is noteworthy that TRPC6 expression closely relates to CPA-induced calcium entry, which contributes to the proliferation of PASMCs [56] . It remains unclear whether TRPC6 exhibits a different phenotype in PASMCs proliferating by heterodimerizing with proteins such as TRPC3, which has been suggested to be a receptor-and store-operated calcium channel [46] , or whether CPA activates TRPC6 through mechanisms other than SR calcium depletion. Recently, numerous evidences have reported that TRPC6 is associated with ROCE [57] [58] [59] [60] . It is unclear if TRPC6 displays a different phenotype among different species, eg, by heteromerization with other TRPC proteins. These interesting possibilities require future investigations. Our data showed that nicotine induces elevation of SOCE and ROCE in H SMCs, leading to enhanced basal [Ca 2+ ] i . This enhancement is potentially correlated with increased expression of TRPC6 and inally contributes to promoting the proliferation of H SMCs. To the best of our knowledge, this is the irst study regarding the importance of TRPC6 in H SMC proliferation. Recent studies also have suggested a key role of TRPC6 calcium entry in the mediation of [Ca 2+ ] i elevation and cell proliferation [61, 62] . ased on the observations from this study, the attenuation of SOCE and ROCE may serve as a potential therapeutic approach for COPD.
Our indings suggest that 7 nAChR is the major nicotinic receptor subtype responsible for upregulation of TRPC6 expression and proliferation in H SMCs. Thus far, 12 different neuronal nicotinic subunits have been identi ied: nine ( 2-10) and three ( 2-4) subunits [63] . Multiple functionally distinct nAChR subunits can be assembled either as homomeric functional pentamers, such as 7 nAChR, or as heteropentamers with at least two different subunits, such as 4 2 nAChRs [64] . We recently became interested in 7 nAChR because of their physiological roles in non-neuronal cells such as macrophages, vascular endothelial cells and aortic smooth muscle cells [65] . In addition, there is growing evidence that 7 nAChR plays an important role in nicotine-mediated signaling transduction pathways in cell proliferation [8] . Some studies have demonstrated that PGE2 promotes cell growth of nonsmall-cell lung cancer ( SC C) by increasing the expression of 7 nAChR [66] . Our results showed that the 7 nAChR-speci ic antagonist MG624 abolished the nicotineinduced elevation of TRPC6 expression, SOCE, ROCE and cell proliferation in H SMCs, which led us to conclude that nicotine speci ically enhances H SMC proliferation through an 7 nAChR-TRPC6-Ca 2+ signaling pathway. It was con irmed in our previous study and other investigations that nicotine can bind to 7 nAChR to regulate cell proliferation [8, [60] [61] [62] [63] [64] . Although nicotine acts via 7 nAChR to promote cell proliferation [67] [68] [69] [70] [71] , it remains to be determined which signaling pathway activation contributed to the pathogenic changes that occurred. Indeed, identifying the signaling mechanisms responsible for these nicotinemediated effects remains a key goal. etween 7 nAChR and TRPC6, phosphoinositide 3-kinase (PI3K) was necessary for the effects induced by nicotine. In this study, we observed that nicotine magni ied the phosphorylation of Akt in a time-dependent manner (0-60 min). In addition, PI3K inhibitor ( 294002) abrogated the nicotine-induced phosphorylation of Akt. Additionally, the related nicotine-induced changes, such as elevated TRPC6 expression, SOCE, ROCE and proliferation of H SMCs were abolished by 294002. Thus, we inferred that nicotine-induced H SMC proliferation is mediated, at least partly, through activation of the Akt pathway. In line with previous observations made in our laboratory that nicotine could induce activation of the Akt pathway in RASMCs, we demonstrated in this study that activation of the Akt pathway, which controls cell proliferation, is a further adaptive response to nicotine. Akt is known as a major downstream target of phosphoinositide 3-kinase (PI3K), which plays a crucial role in a broad range of cellular functions, such as cell survival, migration, division, differentiation, proliferation, etc., in response to extracellular signals [72] . It was recently identi ied that PI3K-mediated signaling pathways are novel regulators of native TRPCs in rabbit coronary artery vascular smooth muscle cells ( SMCs) [73] . It was also reported that the PI3K pathway is involved in the externalization of TRPC6 and TRPC6-dependent calcium entry [74] . Furthermore, it has been well accepted that TRPC6 mediates glucagon-induced increase of [Ca 2+ ] i in glomerular mesangial cells through the cAMP-PI3K-MEK-ERK1/2 axis, which leads to the proliferation of renal mesangial cells [75] .
In summary, calcium appears to be a critical second messenger in the signal transduction underlying the regulation of nicotine-induced cell proliferation. PI3K is activated by G-protein-coupled receptors (GPCR) [76] and is possibly involved in calcium entry [77] . As PI3K is a key protein involved in calcium regulation, we hypothesized that it might in luence the activation of TRPC6. Activation of the PI3K/Akt pathway may increase calcium in lux by stimulating TRPC6. Thus, TRPC6 appears to be a downstream target of the PI3K/Akt signaling pathway in nicotine-treated H SMCs. The PI3K/Akt signaling pathway is a major mechanism through which 7 nAChR mediates cell proliferation. Recent studies have shown that nicotine can induce 7 nAChR-mediated proliferation effects by activating the PI3K/Akt pathway, shedding light on potential therapeutic molecules that could be targeted to combat smoking-associated human diseases [68] . Our study shows that 7 nAChR antagonists or siR A can also suppress Akt phosphorylation.
Conclusion
The results presented here provide evidence that nicotine-induced activation of 7 nAChR enhances TRPC6 expression by phosphorylating Akt at Ser473, leading to increased calcium in lux and ultimately promotion of H SMCs proliferation. Thus, understanding the underlying regulatory mechanisms is of important potential clinical value and may provide further insight regarding new treatment strategies for airway remodeling diseases such as COPD and asthma.
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